The global Patient Positioning Systems market size is expected to reach USD 59.42 billion by 2025, registering CAGR of 8.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. This market is expected to witness lucrative growth owing to rising awareness about and surging expenditure on diagnostic procedures. In addition, the increasing prevalence of cancer and the rising geriatric population are expected to assist in market growth.
The COVID-19 pandemic has made unprecedented consequences on daily lives in addition to the worldwide economy. A significant burden is formed on healthcare systems across the globe. Currently, as the pandemic starts to subside, governments of various countries are focusing on recognizing the cracks in their healthcare infrastructure and are taking initiatives to bolster the same. The market is projected to benefit from this up-gradation of healthcare establishments across the world. For instance, in December 2020, Victorian hospitals received financial support to upgrade infrastructure and equipment.
According to the WHO, Cancer is a leading cause of death globally, reporting for almost 10 million deaths in 2020, or nearly one in six deaths. While as per the National Cancer Institute statistics, there were approximately 16.9 million cancer survivors in the U.S. as of January 2019. The number of cancer survivors is expected to increase to 22.2 million by 2030. The most common types of cancer are breast cancer, prostate cancer, and colon and rectum cancer. This steady increase in disease prevalence acts as a driver for R&D investments in the industry. An increase in innovation has resulted in improved efficiency and accuracy of these systems in cancer therapy. These products keep patients immobile yet comfortable during radiotherapy. This is anticipated to supplement industry growth.
Rising expenditure on diagnostics procedures has been a strong force driving demand in the market. According to research published by NCBI, the majority of oncologists and cardiologists in the U.S. and Germany prescribe diagnostics tests and choose a treatment plan only after studying test results. Thus, the demand for diagnostics tests is increasing globally.
Request a free sample copy or view report summary: Patient Positioning Systems Market Report
By product, the tables segment held a lucrative market share in 2023, owing to the increasing prevalence of cancer and the rising number of surgeries performed
In terms of application, the surgery segment is expected to account for the dominant market share on account of the rising incidence of cancer, globally
By end-use, the ambulatory segment is expected to register the highest growth over the forecast period owing to an increase in precision of minimally invasive technologies
North America is projected to dominate the market over the forecast period due to the presence of a large number of diagnostic centers
The market is fragmented with many big and small industry players. Key players are adopting business strategies such as business expansion, joint ventures, and others
Grand View Research has segmented the global patient positioning systems market on the basis of product, application, end-use, and region:
Patient Positioning Systems Product Outlook (Revenue, USD Million, 2018 - 2030)
Tables
Surgical Tables
Examination Tables
Radiolucent Imaging Tables
Accessories
Patient Positioning Systems Application Outlook (Revenue, USD Million, 2018 - 2030)
Surgery
Diagnostics
Others
Patient Positioning Systems End-use Outlook (Revenue, USD Million; 2018 - 2030)
Hospitals
Ambulatory centers
Others
Patient Positioning Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Patient Positioning Systems Market
Medtronic
Hill-Rom Holdings, Inc.
Stryker Corporation
Medline Industries
Skytron, LLC
Smith & Nephew
STERIS plc
Mizuho OSI
LEONI AG
OPT SurgiSystems Srl
"The quality of research they have done for us has been excellent..."